DePuy Synthes Products Inc. has acquired 3-D printing technology from Tissue Regeneration Systems Inc.
According to a company press release, the deal enables DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopedic and craniomaxillofacial deformities and injuries. The financial terms of the transaction have not been disclosed.
“We are systematically investing in building a pipeline of 3-D printed products,” Ciro Römer, company group chairman at DePuy Synthes, said in the release. “The [Tissue Regeneration Systems] TRS technology, which will be added to the DePuy Synthes Trauma Platform, is the latest example of how we are working toward developing next-generation technologies that transform health care delivery with individualized solutions for patients.”